EAM
CTIC

Eagle Asset Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Eagle Asset Management’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-433,263
Closed -$7.84M – 697
2015
Q1 		$7.84M Sell
433,263
-838,042
-66% -$18.9M 0.04% 366
2014
Q4 		$30M Buy
1,271,305
+485,954
+62% +$11.2M 0.17% 179
2014
Q3 		$19M Buy
785,351
+86,785
+12% +$2.26M 0.11% 212
2014
Q2 		$19.6M Buy
698,566
+26,718
+4% +$803K 0.11% 226
2014
Q1 		$22.8M Buy
+671,848
New +$23M 0.13% 229

Other funds holding CTIC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $186M AUM 35.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return